Head-to-head · computed 2026-08-11
Amble Health vs Gala GLP-1
Amble Health: A no-membership program with $300/month flat tirzepatide. Gala GLP-1: Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149.
Tirzepatide
| Amble Health | Gala GLP-1 | |
|---|---|---|
| All-in maintenance | $300/mo | $179/mo |
| Best plan rate | $300/mo | $179/mo |
| 12-month total | $3,600 | $2,148 |
| Status | Provider-stated · 2026-08-05 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, Gala GLP-1's $179 a month undercuts Amble Health's $300 by $121 a month at the 10 mg/wk maintenance basis — $1,452 across a year. Gala GLP-1's figure is reported (captured 2026-07-14) and Amble Health's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Amble Health's tirzepatide ladder runs $300 a month billed monthly. Gala GLP-1's runs $179 a month billed monthly, and $199 a month on a three-month plan. On the twelve-month basis Gala GLP-1's $2,148 beats Amble Health's $3,600 by $1,452 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
Only Gala GLP-1 offers semaglutide ($179 a month billed monthly, and $199 a month on a three-month plan); Amble Health does not, so there is no contest to score.
Structure, side by side
Amble Health
- MembershipNone
- Dose policyDose-flat
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner pharmacies
Gala GLP-1
- MembershipNone
- Dose policyFlat at 'all doses' for standard plan; separate microdosing tier at $149
- Commitment3-month plan or standard monthly; confirm exact terms at enrollment
- CancellationPer provider terms
- PharmacyPartner 503A pharmacies (not named publicly)
What our desk is watching on each
Amble Health: Provider-stated; checkout capture pending.
Gala GLP-1: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.
Questions people ask
Is Amble Health or Gala GLP-1 cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Amble Health vs Gala GLP-1 miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Amble Health and Gala GLP-1 cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $3,600 at Amble Health and $2,148 at Gala GLP-1 — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Amble Health · Gala GLP-1. Official sites: Amble Health ↗ · Gala GLP-1 ↗. Nothing here is medical advice.